Chongqing Pharscin Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 202.99 million compared to CNY 230 million a year ago. Revenue was CNY 202.99 million compared to CNY 230 million a year ago. Net income was CNY 29.35 million compared to CNY 36.47 million a year ago. Basic earnings per share from continuing operations was CNY 0.0732 compared to CNY 0.0911 a year ago. Diluted earnings per share from continuing operations was CNY 0.0732 compared to CNY 0.0911 a year ago.